SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the November 22 target date and the companys amended application emphasizing upper-limb function data. Bullish traders interpret the longer-term data, rare-disease policy discussions and recent commercial hiring as encouraging signs, while skeptics cite prior FDA concerns and say approval remains uncertain.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention for its breakout ahead of the expected Q3 earnings report, with traders focused on BRIUMVIs growth and possible further upside. Buyout and short-squeeze chatter is prominent but speculative; some traders instead attribute the move to earnings expectations and the companys commercial momentum.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could fall after early 2027 has fueled a sharp selloff and concern about future pricing and revenue. Traders disagree over whether the warning signals sustained pressure or is only a preliminary estimate, pointing to CMSs more stable outlook while criticizing CorMedixs lack of clarification.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp Nasdaq selloff tied to weakness in technology and semiconductor stocks, with traders debating whether concerns about AI spending and earnings justify more downside or whether the decline is an oversold dip to buy. The late-session rebound prompted some dip-buying optimism, but bearish traders continued to warn that the correction may not be over.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS REGAL Phase 3 leukemia trial reached its prespecified event threshold, triggering final analysis and putting the GPS survival readout in focus. Traders are sharply divided over whether GPS will show a benefit or whether control-arm outcomes and trial assumptions could undermine the bull case, amid volatile trading and speculation about short positioning.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigens PAPZIMEOS commercial launch and stronger-than-expected quarterly results, including a move to profitability, are driving bullish discussion about its growth prospects. Traders also debate whether potential INO-3107 competition could challenge PAPZIMEOS and whether heavy short interest is amplifying the stocks moves.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A reported major Binance security breach and temporary withdrawal suspension have fueled Bitcoin selling and concerns about crypto exchange security. Traders disagree over whether the incident signals broader risk or is isolated to Binance, with some viewing the pullback as a buying opportunity and others warning of further downside.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

ARM is caught in a sharp semiconductor and AI-stock selloff, with traders citing its rich valuation and questioning whether AI demand can support the growth priced in. Some see the drop as an overdone sector-driven correction and are buying the dip, while others expect further downside.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its quarterly report is fueling concern about slowing ad growth, analyst target cuts, and weakness across advertising-related stocks. Traders debate whether the decline reflects deteriorating prospects or has overshot the companys growth and cash-generation fundamentals, with earnings seen as a key test.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

Silvers sharp selloff, amid inflation concerns and expectations of higher interest rates, is driving attention to SLV. Traders are split between calling the decline an oversold buying opportunity and warning that selling may continue, with some blaming market manipulation without evidence.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Does Ryder Stock's Q3 Earnings Beat Justify a Buy Decision Today?

We assess the investment worthiness of Ryder stock post its third-quarter 2026 earnings release.

What's in the Offing for International Seaways in Q3 Earnings?

INSW gears up for Q3 earnings, with sharply higher profit and revenue estimates as strong tanker rates may offset fuel costs and demand uncertainty.

FDXF Four-Month Transition Period Earnings Beat Estimates on Higher Yields

FedEx Freight beat four-month transition period 2026 earnings estimates as higher freight yields and fuel surcharges boost revenues, prompting an upgraded transition-period earnings outlook.

AER vs. WAB: Which Stock Is the Better Value Option?

LSTR Q3 Earnings Beat Estimates on Strong Freight Pricing

Landstar's Q3 2026 earnings and revenues beat estimates as strong truck pricing and higher freight volumes fueled growth, despite insurance cost pressures.

ODFL Q3 Earnings Beat Estimates on Strong Yield and Cost Control

Old Dominion's Q3 2026 earnings and revenues beat estimates as stronger pricing and improved operating efficiency drive growth despite persistent freight volume pressures.

JetBlue Airways Q3 Earnings Miss Estimates on Higher Fuel Costs

JBLU's Q3 2026 loss widens as surging fuel costs offset strong revenue growth, while higher RASM guidance and JetForward goals signal a profitability push.

Ryder System Shares Rise 2% Since Third-Quarter 2026 Earnings Release

R's Q3 2026 earnings and revenues beat estimates, fueled by strong fleet management performance, prompting higher full-year earnings guidance.

KNX Q3 Earnings Beat Estimates on Truckload Pricing Gains

Knight-Swift's Q3 2026 earnings surged on stronger truckload pricing and network efficiency, beating estimates despite a post-earnings stock decline.

NSC Q3 Earnings Beat Estimates on Record Revenues, Volume Growth

Norfolk Southern's Q3 2026 earnings and revenues beat estimates, driven by higher fuel surcharges and volume growth, even as rising expenses pressured margins.

Westinghouse Air Brake Technologies Corp. engages in the provision of equipment, systems, and value-added services for the rail industry. It operates through the Freight and Transit segments. The Freight segment builds new locomotives, manufactures and services components for new and existing freight cars and locomotives, rebuilds freight locomotives, supplies railway electronics, positive train control equipment, and signal design and engineering services, and provides related heat exchange and cooling systems. The Transit segment manufactures and services components for new and existing passenger transit vehicles, including regional trains, high speed trains, subway cars, light-rail vehicles, and buses, builds new commuter locomotives, refurbishes subway cars, and provides heating, ventilation, air conditioning equipment, and doors for buses and subway cars. The company was founded in 1869 and is headquartered in Pittsburgh, PA.

Westinghouse Air Brake Technologies Corp

Why Did WAB Stock Hit A Record High Today?

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Wabtec raised its full-year 2026 revenue guidance to $12.3 billion to $12.6 billion.</li><li>The firm said sales growth was supported by higher demand in both freight and transit business segments.</li><li>Earnings rose 21.6% to $2.76 per share, beating the consensus estimate of $2.61.</li></ul>Shares of Westinghouse Air Brake Technologies Corp. (WAB), or Wabtec, surged nearly 12% to a fresh record high on Wednesday after the company topped second-quarter expectations and lifted its full-year 2026 revenue and earnings forecasts, sparking investor optimism.<a href="https://stocktwits.com/symbol/WAB">WAB stock</a> also recorded its biggest single-day gains since November 2020.<h2 class="st-heading-2">Wabtec Raises FY2026 Guidance As Order Book Grows</h2>The rail equipment maker posted revenue of $3.18 billion, up 17.5% from a year earlier and above analysts' expectations of $3.07 billion, according to Fiscal.ai data. Adjusted earnings rose 21.6% to $2.76 per share, topping the consensus estimate of $2.61.The company also highlighted its strong order book, with a multi-year backlog of $30.93 billion and 12-month backlog growth of 11.3%. Backed by this momentum, Wabtec raised its full-year 2026 revenue guidance to $12.3 billion to $12.6 billion and increased its adjusted earnings per share outlook to $10.6 to $10.9.<h2 class="st-heading-2">Recent Acquisitions Shine Despite Headwinds</h2>Wabtec said sales growth was supported by higher demand in both freight and transit business segments, including contributions from the acquisitions of Inspection Technologies, Frauscher Sensor Technologies, and Dellner Couplers.Wabtec said its recent acquisitions are off to a strong start despite broader macroeconomic headwinds.“Despite the headwinds we still face with inflationary pressures, still managing through tariffs, and chip shortages with the impact to electronics. I think the other item to highlight is the acquisitions, which continue to perform very well early days,” said Rafael Santana, Chairman and CEO, Wabtec, in a call with analysts.Wabtec acquired Dellner Couplers, a Sweden-based firm developing safety-critical train connection systems, in February this year and Frauscher Sensor Technology Group, a train detection, wayside object control solutions, and axle counting systems maker, in December last year.<h2 class="st-heading-2">Retail’s Take On WAB</h2>Meanwhile, retail sentiment surrounding WAB on Stocktwits turned ‘bullish’ from ‘bearish’ amid ‘high’ message volumes.The stock has gained around 36% so far this year.Also read:<a href="https://stocktwits.com/news-articles/markets/equity/flnc-csiq-nrgv-stocks-get-citi-upgrade-ahead-of-quarterly-earnings/cZZmkCdR7D7">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/france-says-tesla-s-fsd-falls-short-of-safety-bar-retail-turns-focus-to-q2-earnings/cZZmZtHR7DQ">France Says Tesla’s FSD Falls Short Of Safety Bar – Retail Turns Focus To Q2 Earnings</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Close up of stock market chart on a glowing particle world map. (Source: Getty Images)

Shares of Westinghouse Air Brake Technologies Corp. (WAB), or Wabtec, surged nearly 12% to a fresh record high on Wednesday after the company topped second-quarter expectations and lifted its full-year 2026 revenue

The rail equipment maker posted revenue of $3.18 billion, up 17.5% from a year earlier and above analysts' expectations of $3.07 billion, according to Fiscal.ai data.


Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$2.67	$2.10	-21.37%	MISSED
Q3 '26	$2.73	$2.83	3.54%	BEAT
Q2 '26	$2.61	$2.76	5.94%	BEAT
Q1 '26	$2.51	$2.71	7.94%	BEAT
Q4 '25	$2.08	$2.10	0.81%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

WAB Earnings

Latest Earnings Results: Q4 '26

Historical Earnings